On the other hand, sodium benzoate—an add-on treatment for treating schizophrenia—acts as an inhibitor of D-amino acid oxidase (DAAO), a peroxisomal flavoenzyme that is almost exclusively expressed within astrocytes, therefore increasing D-amino acid levels (Figure 2 and Table 3) [314]. Here, DAO is linked to schizophrenia.